← Back to Search

Neurofeedback

PRISM for Attention Deficit Hyperactivity Disorder (ADHD)

N/A
Waitlist Available
Led By Lenard Adler, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Any gender
Not requiring treatment for any comorbid psychiatric condition for at least 2 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 11
Awards & highlights

Study Summary

This trial is testing a new neurofeedback intervention to see if it's feasible. If it is, it may help people with down-regulation of deep limbic structures, specifically the amygdalae.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You do not require treatment for any comorbid psychiatric condition for at least 2 months.
Select...
Subjects who are not receiving any pharmacological treatment for ADHD must have an AISRS score of ≥ 28 at screening
Select...
You do not intend to change medication or psychotherapy for the duration of the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 11
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 11 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Score on Adult ADHD Investigator Symptom Rating Scale (AISRS)
Score on Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5-Expanded (DSM-5 ASRS Expanded)
Score on Behavioral Rating Inventory of Executive Function- Adult Version (BRIEF-A) Self-report

Trial Design

1Treatment groups
Experimental Treatment
Group I: Participants with ADHDExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PRISM
2016
N/A
~170

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,359 Previous Clinical Trials
817,195 Total Patients Enrolled
12 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
678 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Lenard Adler, MDPrincipal InvestigatorNYU Langone Health
4 Previous Clinical Trials
172 Total Patients Enrolled
3 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
120 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New York
Pennsylvania
How old are they?
18 - 65
What site did they apply to?
NYU Langone Health
What portion of applicants met pre-screening criteria?
Met criteria
~5 spots leftby Mar 2025